Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Oct 01, 2012
New Technologies in Particle Design. Interview: Colin Minchom, VP, Particle Design Business Unit
Read more
Scientific Article
Scientific Article
/ Mar 01, 2013
Applying Quality by Design to spray drying - The role of empirical and mechanistic modelling
Read more
Scientific Article